Target Therapy in HER2-Overexpressing Breast Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Target Therapy in HER2-Overexpressing Breast Cancer Patients

Published:2011-06 Issue:6 Volume:15 Page:363-367
ISSN:1536-2310
Container-title:OMICS: A Journal of Integrative Biology
language:en
Short-container-title:OMICS: A Journal of Integrative Biology

Author:

Amodio Rosalba¹,Zarcone Maurizio²³,Cusimano Rosanna¹⁴,Campisi Ildegarda²,Dolcemascolo Cecilia²,Traina Adele²³,Agostara Biagio²,Romano Nino¹

Affiliation:

1. Palermo Province Cancer Registry, Department of Science for the Promotion of Health “G.D. Alessandro,” University of Palermo, Italy.

2. Palermo Breast Cancer Registry and Experimental Oncology, Department of Oncology, ARNAS-Civico, Palermo, Italy.

3. Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

4. Department of Epidemiology of ASL6, Palermo, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology

Link

http://www.liebertpub.com/doi/pdf/10.1089/omi.2010.0125

Reference16 articles.

1. Medicare and Chronic Conditions

2. Her2 cross talk and therapeutic resistance in breast cancer

3. Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene

4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

5. Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Guanosine and Guanine Nucleotides Decrease Viability of Human Breast Cancer SKBR-3 Cells;Biological and Pharmaceutical Bulletin;2024-01-01

2. D-Dimer beyond Diagnosis of Pulmonary Embolism: Its Implication for Long-Term Prognosis in Cardio-Oncology Era;Journal of Personalized Medicine;2023-01-27

3. Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer;Breast Cancer;2021-02-16

4. Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast;2020-06-25

5.

Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle

;International Journal of Nanomedicine;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3